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Voltage clamp measurements reveal important insights into the activity of membrane ion channels. 
While conventional voltage clamp systems are available for laboratory studies, these instruments 
are generally unsuitable for more rugged operating environments. In this study, we present a non-10 
invasive microfluidic voltage clamp system developed for the use under varying gravity levels. 
The core component is a multilayer microfluidic device that provides an immobilisation site for 
Xenopus laevis oocytes on an intermediate layer, and fluid and electrical connections from either 
side of the cell. The configuration that we term the Asymmetrical Transoocyte Voltage Clamp 
(ATOVC) also permits electrical access to the cytosol of the oocyte without physical introduction 15 
of electrodes by permeabilisation of a large region of the oocyte membrane so that a defined 
membrane patch can be voltage clamped. The constant low level air pressure applied to the oocyte 
ensures stable immobilisation, which is essential for keeping the leak resistance constant even 
under varying gravitational forces. The ease of oocyte mounting and immobilisation combined 
with the robustness and complete enclosure of the fluidics system allow the use of the ATOVC 20 
under extreme environmental conditions, without the need for intervention by a human operator. 
Results for oocytes over-expressing the epithelial sodium channel (ENaC) obtained under 
laboratory conditions as well as under conditions of micro- and hypergravity demonstrate the high 
reproducibility and stability of the ATOVC system under distinct mechanical scenarios. 
Introduction 25 
The regulated movement of selected ion species through ion 
conducting channels in the plasma and intracellular 
membranes is essential for cell survival as well as cellular 
functions such as osmoregulation and intra- and intercellular 
signalling.1 Disturbance to ion channel function undermines 30 
cell survival and may potentially manifest itself as a diseased 
state on the organismal level.2 Ion channel function can be 
physiologically regulated by chemical, physical or mechanical 
gradients. The actions of chemical and pharmacological 
agents such as channel blockers and modulators of ion 35 
channel function have been well characterized and the 
underlying molecular mechanisms elucidated; in contrast, the 
role and influence of physical and mechanical stresses is less 
clear. Mechanical stimulation such as shear forces and 
mechanical strain is known to induce rearrangements of the 40 
cell’s mechanotransductive apparatus, including the 
cytoskeleton, as well as the expression pattern of cell-
regulatory proteins that in turn can modulate ion channel 
activity.3, 4 
 Previous studies have shown that gravitational force 45 
influences the activity of ion channels involved in cellular 
mechanotransduction.5, 6 In this context, it has been shown 
that muscle cells are particularly vulnerable to reductions in 
gravitational force, ultimately leading to muscle atrophy in 
response to chronic exposure to a low gravity environment.7, 8 50 
Moreover, intracellular calcium, a ubiquitous cellular second 
messenger, is also responsive to gravitational force, which in 
turn, would modulate channel or pump activity.9 Finally, some 
cation channels are both calcium conductive and 
mechanically-regulated, uniting both modalities of cellular 55 
response influenced by gravitational forces.10 Given the 
importance of proper ion channel function for cell survival 
and metabolism, and the inherent difficulties of making 
electrophysiological recordings under conditions of altered 
gravitational force, we initiated a multidisciplinary 60 
collaboration with the aim of designing a stable and 
automated recording platform to reliably monitor the 
biophysical consequences of altered gravitational forces on 
ion channel activity. 
 Characterization of ion channels is usually performed by 65 
controlling the transmembrane potential and simultaneously 
measuring the resulting transmembrane current (voltage 
clamp). Laboratory-based voltage clamp systems commonly 
use glass microelectrodes (intracellular, or patch) to control 
the transmembrane voltage. These electrodes are fragile and 70 
require careful micromanipulation by the operator. Recently, 
the feasibility of planar electrodes manufactured from 
poly(dimethylsiloxane) (PDMS)11, 12 or glass13 has been 
successfully demonstrated, thereby providing a reliable and 
robust alternative to glass microelectrodes and, importantly, 75 
obviating the need for micromanipulation typically required 
for patch clamping. Moreover, a number of microfluidic chips 
for performing planar patch clamping under laboratory 
conditions has been developed recently.14-17 Advances in 
automated electrophysiology have demonstrated that 80 
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reproducible recordings can be obtained without significant 
operator intervention.18 Nevertheless, these devices are 
generally designed for operation under standard laboratory 
conditions, and are not suitable for remote operation in a 
physically demanding environment. On the other hand, 5 
specialised microfluidic devices have been realised for use 
under extreme environmental conditions such as the sea19 or 
the Martian atmosphere.20 The implementation and 
optimization of a voltage-clamp device for studies under 
varying gravity conditions is particularly challenging, since 10 
changes in gravity are associated with alterations of the 
mechanical environment with profound physiological 
consequences, be it on an aeroplane (e.g. during parabolic 
manoeuvres), sounding rocket, or in ground laboratory-based 
systems such as random position machines, 3D clinostats or 15 
centrifuges.  
 The core module of our system is a multilayer microfluidic 
chip that allows for stable positioning of a single cell (in our 
case, a Xenopus laevis oocyte) and accurate determination of 
the current passing across the entire cell membrane in 20 
response to an externally imposed transcellular electrical 
potential. Our design, which we term the asymmetrical 
transoocyte voltage clamp (ATOVC) is akin to the previously 
described loose macropatch voltage clamp21, 22 and 
transoocyte voltage clamp (TOVC),23 however in our system 25 
only a small, well-defined patch of the oocyte membrane is 
exposed to test solutions. This has two consequences: (i) it 
facilitates the fast exchange of fluids exposed to the 
membrane patch through the microperfusion layer of the 
device, yet only requires low solution volumes; (ii) by 30 
permeabilising the remainder of the cell membrane we can 
readily gain electrical access to the cell interior and achieve 
voltage clamping of the patch. The microfluidic device is 
made of PDMS and encapsulated in a PMMA assembly that 
comprises fluid, pressure and electronic connections. A 35 
similar design was previously described by Dahan et al.14 but 
did not incorporate a fully enclosed cell recording chamber 
and fluidics. We now describe how this concept was 
specifically adapted and modified to satisfy our design criteria 
by incorporating a cell immobilisation feature and, moreover, 40 
by having a liquid- and airtight system.  
 To demonstrate the feasibility of our system, we have 
performed measurements on Xenopus laevis oocytes that 
heterologously expressed the amiloride-sensitive epithelial 
sodium channel (ENaC). This channel was chosen because of 45 
its high specificity, fast kinetics and documented sensitivity to 
mechanical stimuli.3, 24, 25 The advantages of the oocyte 
expression system in the context of gravity research is that 
these cells are extremely robust and they can be easily 
transported, maintained and handled without requiring special 50 
incubation conditions or stringent sterility procedures. 
Moreover, after removal from the frog, they can be kept 
healthy for typically up to a week, provided the incubation 
temperature remains below 20 °C. A further unique feature of 
Xenopus laevis oocytes is that their orientation with respect to 55 
the Earth’s gravitational field is well defined, with the easily 
identified animal pole (pigmented hemisphere) facing 
upwards for healthy cells. 
 In addition to extensive laboratory testing under 1 g 
conditions, our system has been successfully used in a 60 
parabolic flight campaign in Bordeaux (F) under the auspices 
of the European Space Agency (ESA) and in the Large 
Diameter Centrifuge (LDC) at the European Space Research 
and Technology Center (ESTEC) at Noordwijk (NL). 
Principle of the ATOVC 65 
Previously described electrophysiology techniques such as the 
TOVC23 and the loose macropatch voltage clamp21, 22 do not 
involve physical disruption of the membrane and therefore 
allow non-invasive electrophysiological measurements of 
membrane protein activity. For the TOVC, the oocyte is 70 
positioned in an orifice separating two fluid-filled 
compartments resembling an Ussing chamber and the 
electrical potential between the compartments is controlled to 
measure the transoocyte current. This arrangement has been 
used for transoocyte noise and impedance measurements.23 In 75 
the loose macropatch,21, 22 the extracellular potential is 
operator-defined and current is measured from a small 
membrane patch by means of a glass pipette that lightly 
touches the cell membrane. For both methods, some of the 
current measured results from leakage because the membrane 80 
is not perfectly sealed to the orifice or patch pipette, 
respectively. Importantly, the transmembrane potential is 
poorly defined because the intracellular potential is unknown 
and in the case of large currents, errors in membrane voltage 
control may occur. One solution to this problem was recently 85 
described by Dahan et al.,14 in which a defined area of the 
oocyte membrane was permeabilised using an ionophore to 
allow a low resistance access to the cytosol. 
 As in the Dahan approach, we have used a conical structure 
with a small hole which separates the two fluid filled 90 
compartments. With the oocyte in place, this effectively 
divides the oocyte membrane surface into a lower “patched” 
region that is exposed to a microfluidic perfusion channel, and 
an upper “body” region that is exposed to the upper 
compartment. The surface area of the patch membrane is 95 
much smaller than the surface area of the entire oocyte (Fig. 
S2, S3) and in this context, the arrangement can be considered 
a variation of the loose macropatch.21, 22 By defining the 
electrical potentials in the two compartments, our system 
offers the flexibility of allowing transoocyte impedance 100 
measurements as for the TOVC23; loose macropatch 
measurements21, 22 and, by permeabilising the body 
membrane, we can gain electrical access to the cytosol.14 Due 
to the uneven surface topology of the oocyte membrane and 
associated vitelline layer,26 it is impossible to fully prevent 105 
ohmic leakage currents passing around the cell between the 
two compartments. However, these leak currents will remain 
constant, assuming the oocyte is stabilised. Moreover, they 
can be eliminated when control and test recordings are 
subtracted from one another. 110 
Materials and methods 
Fabrication of the core microfluidic module 
The design and realisation of the microfluidic module is  
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Fig. 1 (a) Exploded view of rendered 3D CAD data used for the 
fabrication of the PMMA parts. The bottom electrodes are inserted into 
the PDMS microchip using 1/16 inch PFA tubing as a sleeve (tubing not 
shown for clarity). (b) Cross-section view of rendered 3D CAD schematic 
of the assembled microfluidic module. (c) Photograph of the microfluidic 5 
module. (d) Design of the microfluidic channels in PDMS. The solution 
exchange volume is given approximately by the length of the main 
channel times its cross sectional area (in our case approx. 1 µl). The exact 
volume is smaller due to the protrusion of the pellet electrodes and part of 
the oocyte patch into the channel. 10 
shown in Fig. 1. The perfusion microchip was made of PDMS  
 (Sylgard, Dow Corning) by moulding from a structured 
silicon wafer.27 The wafer was made from a high-viscosity 
positive resist (SU-8 2100, Microchem) employing standard 
lithography technology. Using a slow spinning step (500 RPM 15 
for 30 s), a final structure height of approximately 500 µm 
was obtained. This channel height was chosen to minimise the 
susceptibility to channel blockage should the oocyte become 
damaged and pass through the hole and to facilitate the 
integration of the Ag/AgCl electrodes. A precisely machined 20 
polytetrafluoroethylene (PTFE) frame was aligned with the 
master structures to obtain a PDMS microchip with exact 
dimensions on all axes (24 x 24 x 8mm3) and a centred 
microfluidic structure. Well-defined curing conditions were 
used to keep the shrinkage of PDMS constant.28 A ratio of 1:8 25 
of curing agent to prepolymer was used for easier removal of 
the cured PDMS from its mould and for higher dimensional 
stability. Curing was done in an oven at 100°C for 1 hour. 
After removal of the PDMS microchip from its mould, 1 mm 
wide holes were punched at predefined positions using a 30 
biopsy puncher. These access holes were necessary for 
interfacing the fluid pathways and the sintered Ag/AgCl 
electrodes (Ag/AgCl 1 mm pellets, Warner Instruments, CT). 
The perfusion microchip was finally integrated with 3 CNC-
machined polymethylmethacrylate (PMMA) parts that serve 35 
multiple functions such as interfacing, sealing and oocyte 
accommodation (Fig. 1a).  
 An important feature of the assembly is the clamping of the 
PDMS microchip between the PMMA parts. The thickness of 
the microchip is slightly larger than the cavity of the PMMA 40 
parts, resulting in compression of the microchip and perfect 
sealing of the microfluidic pathways. Moreover, as a result of 
the PDMS moulding process, the oocyte patch hole in the 
PMMA is automatically aligned with the perfusion channel 
when the device is assembled. 45 
 In the present system we opted for a 300 µm diameter patch 
hole, which results in a sphere to patch surface ratio of 43 
(Fig. S3a), giving a good compromise between electrical 
access to the cytosol, signal-to-noise ratio and mechanical 
stability. 50 
Realisation of the peripheral fluidic and air pressure system  
The scheme of the fully closed peripheral system is depicted 
in Fig. 2. To provide the pressure source we used a small air 
bottle (Sure/Pac 275 ml, Sigma-Aldrich). To control the 
pressure on the fluids, we used an electronic pressure 55 
regulator with feedback control (T3110, 1000 mbar, Marsh-
Bellofram). The output pressure of the regulator pressurised 
glass vials filled with the perfusion fluids. Switching between 
the fluids was achieved by using solenoid valves 
(LFVA1220110H, Lee Co.). Teflon capillary tubes (0.25 mm 60 
inner diameter, 30 cm length) between the solution vials and 
the solenoid valves ensured a well-defined steady-state flow 
rate through the microfluidic module. To reduce the water 
hammer effect resulting from the switching action of the 
valves, air pocket elements between the valves and the 65 
microfluidic device were introduced. The outlet of the 
microfluidic device was connected to an expandable 
polypropylene reservoir29 acting as a sealed waste container. 
For the pressurization of the oocyte a second pressure 
regulator was used (T3110, 68 mbar, Marsh-Bellofram). To 70 
avoid large pressure transients and fluctuations a 
compensation volume between the regulator and the 
microfluidic device was introduced.  
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Fig. 2 Schematic of the peripheral system. Yellow denotes air, blue denotes liquid and grey denotes an electrical connection. 
Reagents and solutions 
Modified Barth’s solution for storing oocytes contained (in 
mM): 88 NaCl, 1 KCl, 0.41 CaCl2, 0.82 MgSO4, 2.5 NaHCO3, 
2 Ca(NO3)2, 7.5 HEPES. The solution was adjusted to pH 7.5 5 
with Tris and supplemented with 5 mg/l doxycycline and 5 
mg/l gentamicine. For storage of oocytes after the injection, a 
low Na+ Barth’s solution was used with the Na+ concentration 
reduced to 10 mM and replaced with 78 mM methyl-d-
glucamine (NMDG). Standard extracellular solution (100Na) 10 
contained (in mM): 100 NaCl, 2 KCl, 1.8 CaCl2, 10 HEPES, 
pH 7.4 adjusted with TRIS. The 10 mM Na+ test solution 
(10Na) had the same composition as 100Na except that 90 
mM of the NaCl was replaced with choline chloride. For test 
solutions containing amiloride, this was added from 100 mM 15 
stock (in DMSO) immediately prior to priming the solution 
reservoirs (see below) to give a final concentration of 10 µM. 
All standard reagents were obtained from either Sigma-
Aldrich or Fluka. 
Oocyte preparation 20 
Female X. laevis frogs were purchased from Xenopus Express 
(France) or African Xenopus Facility (R. South Africa). 
Portions of ovaries were surgically removed from frogs 
anesthetized in MS222 (tricaine methanesulphonate) and cut 
in small pieces. Oocytes were treated for 45 min with 25 
collagenase (crude type 1A) 1 mg/ml in 100Na solution 
(without Ca2+) in presence of 0.1 mg/ml trypsin inhibitor type 
III-O. Healthy stage V-VI oocytes were selected, maintained 
in modified Barth’s solution at 16 °C and injected with 5 ng 
total of cRNA of the α,β,γ sub-units of the Xenopus isoform of 30 
ENaC according to previously described procedures in our 
laboratory.30 After injection, the oocytes were incubated for 3 
days at 16 °C in the low Na+ Barth’s solution (10 mM) to 
maintain a low intracellular Na+ concentration and ensure cell 
survival. Non-injected oocytes of the same batch were used as 35 
a negative control as the amiloride-sensitive inhibition of 
endogenous mechanically sensitive channels is only detected 
under tight seal patch conditions and the microvilli and 
invaginations present in the healthy stage VI oocyte 
membrane are thought to buffer direct mechanical activation 40 
of these channels in the intact oocyte. 31, 32 
Voltage clamp hardware and system controller 
The general arrangement of the voltage clamping hardware 
configuration is detailed in the ESI (Fig. S1). It was designed 
to be easily adapted to perform different electrophysiological 45 
measurements such as transimpedance and loose macropatch 
voltage clamping. For the experiments described in the 
present study, aimed at voltage clamping the patch membrane 
itself, the electrical potential in the compartment facing the 
oocyte patch (microfluidics channel) was defined as signal 50 
ground by means of a virtual ground amplifier connected to 
the two electrodes in the microfluidics channel. The electrical 
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potential in the upper compartment was defined by the input 
command potential using a conventional two electrode voltage 
clamp (TEVC) arrangement connected to the two upper 
compartment electrodes. The analogue command potential, 
defined according to the proprietary control software, was 5 
generated by a 16 bit DAC in the microcontroller unit. Two 
analogue signals were measured: the potential of the upper 
compartment and net current passing between the two 
compartments. They were acquired by 16 bit ADC’s in the 
microcontroller unit with timing and sampling rates defined 10 
by the proprietary software user interface. Data were written 
automatically to a removable solid-state memory device. The 
pressure controllers and fluid solenoid valves were driven 
from the microcontroller unit by pulse width modulation and 
TTL signals, respectively. The microcontroller unit was a 15 
fully customised design (Interstate University for Technology 
Buchs (NTB), Switzerland) based on the MPC555 
microcontroller with a number of connected peripherals. The 
unit could be connected to a computer for direct human 
control or operated fully automatically with data continuously 20 
written to removable media via a USB interface.  
Results 
System evaluation under standard laboratory conditions 
We first optimised the entire system in the laboratory 
environment to verify its robustness and ease of operation. 25 
The best conditions for cell immobilisation were evaluated. 
To ensure the cell remained correctly and stably positioned on 
the patch hole, we applied a constant and well-defined air 
pressure to the upper compartment. This pressure served two 
purposes: (i) it increased the leak resistance between the two 30 
compartments around the oocyte by counteracting forces 
acting on the oocyte resulting from the flow inside the 
perfusion channel - if the air pressure in the bath is high 
compared to the pressure resulting from the perfusion flow, 
the leak resistance will become independent of the flow rate 35 
inside the perfusion channel; (ii) when in operation it served 
to ensure that any effects of gravitational forces on the leak 
resistance were negligible and therefore allowed the system to 
operate under microgravity conditions. Tests for determining 
the influence of variations in the pressure differentials on the 40 
leak resistance were performed to demonstrate its low 
susceptibility to changing environmental conditions (Fig. S6). 
 To demonstrate the viability of the system for monitoring 
the membrane conductance change of the patch under voltage 
clamp conditions, we used oocytes that overexpressed a 45 
channel with known properties, namely the epithelial sodium 
channel (ENaC). The large macroscopic conductance 
associated with ENaC expression meant that the conductance 
of the cell membrane exposed to the upper compartment 
established a low resistance electrical access to the cytosol 50 
and the cytosolic side of the patch.‡ Moreover, as ENaC can 
be reversibly blocked by application of the inhibitor 
amiloride, the leak current between the two compartments 
could be eliminated by subtraction of recordings made in the 
presence of amiloride from control recordings. For these 55 
experiments, the perfusion system was filled with the 100Na,  
Fig. 3 (a) Real-time current measurement on an ENaC expressing oocyte. 
The transoocyte voltage was kept constant at -50 mV except immediately 
before switching solutions where voltage sweeps where applied as 
indicated. The blue line represents the initial current demonstrating the 60 
steady-state stability before and after the solution switching procedure. 
The flow rate was kept constant at 1 µl/s. (b) Four I-V curves from one 
selected oocyte measured consecutively at the times indicated. (c) I-V 
curve representing the average of 5 oocytes and normalized to the current 
at -100 mV. The mean reversal potential is approx. +20 mV. For the data 65 
in plots b and c a voltage ramp from -200 mV to +100 mV with a period 
of 20 s was applied. 
100Na + amiloride and 10Na solutions, and the oocyte was 
placed in the chamber together with approximately 200 µl of 
10Na solution. The amiloride concentration (10 µM) was used 70 
to ensure the complete inhibition of all ENaCs exposed to the 
microperfusion channel.33 The top PMMA plate was 
positioned and fixed with screws and the oocyte compartment 
was pressurised at 20 mbar. Various leak evaluation tests had 
shown that this value was the best compromise between 75 
maximising the leak resistance (typically in the range of 150 
to 200 kΩ for 10Na) and minimising stress to the oocyte 
membrane. We found that increasing the pressure beyond 20 
mbar did not yield a substantial increase in leak resistance, 
most probably because the area of the contact between the 80 
oocyte and funnel remained unchanged and the oocyte would 
simply be pushed through the hole further. Furthermore, 
oocytes pressurized at 50 mbar and beyond tended to burst 
after a few minutes.  
 After top pressurization, the perfusion system was started 85 
and the oocyte constantly perfused with 10Na solution to 
replicate the standard incubation conditions and avoid loading 
the cells with sodium. It was found that the oocyte typically 
required 3 to 5 minutes to reach a stable condition after 
starting pressurization. The perfusion sequence was then 90 
initiated (Fig. 3a), which consisted of switching from 10Na 
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solution to perfusion with 100Na solution for 10-20 s 
followed by 100Na solution containing 10 µM amiloride for 
10-20 s. This was followed by a washout in 10Na solution to 
return to the initial conditions. The individual steps of the 
perfusion procedure as well as the measurement parameters 5 
were configured by the software. Two electrophysiological 
characterisations were performed using the system: time-
dependent current measurements at a constant holding 
potential and current-voltage (I-V) characterizations using a 
voltage ramp or voltage step sequence. 10 
 Fig. 3a shows a representative steady-state recording at a 
transoocyte potential of -50 mV (upper compartment relative 
to lower compartment) for an ENaC overexpressing oocyte 
subjected to the perfusion sequence indicated. Assuming a 
solution exchange volume of approximately 1 µl, the solution 15 
exchange time is around 1 s for the flow rate we used (1 µl/s, 
Fig. 3a), giving reasonable response time of the microfluidic 
exchange. The rapid response to the application of amiloride 
within a few seconds for the ATOVC confirms the good 
performance of this system. The I-V relation of the amiloride-20 
sensitive current (Fig. 3b) for repeated applications and wash-
out on the same oocyte at the time intervals indicated shows 
that the system responded reproducibly with little change in 
the currents between successive measurements. For this cell, 
the reversal potential remained constant and indicated that the 25 
internal [Na+] did not change significantly between successive 
measurements. Moreover, comparison of I-V traces agreed 
well with the TEVC recording (Fig. S5b). 
 The curvilinear nature of the I-V reflects the typical 
amiloride-sensitive macroscopic current carried by ENaC as 30 
previously reported.34 This characteristic shape was found for 
oocytes overexpressing different levels of ENaC. Fig. 3c 
shows the I-V traces obtained from 5 different oocytes with 
amiloride-sensitive currents varying from -28 nA to -80 nA (at 
-50 mV). The data were normalized to the current at -100 mV 35 
and superimposed to show that the voltage dependence was 
unchanged, independent of expression level. The reversal 
potential of (+20 ± 10) mV is lower than predicted (+59 mV) 
from the assumed 10:1 Na concentration gradient across the 
patch membrane. As this did not change significantly with 40 
expression level it is unlikely that it resulted from inadequate 
voltage control of the patch membrane, but rather suggests 
that the internal [Na+] was higher than assumed.  
 Finally, we tested the system on two different laboratory 
shakers providing either horizontal or wave-like movements 45 
(see ESI, movie 1 and 2). The output signals were not affected 
by the movement, which confirmed the high stability and 
robustness of the system. 
Measurements under hypergravity 
To study if extended periods of hypergravity affected the 50 
macroscopic conductance of ENaC overexpressing oocytes, 
we conducted tests on a Large Diameter Centrifuge (LDC) 
provided at the European Space Research and Technology 
Center (ESTEC) at Noordwijk (NL). The entire system was 
mounted in a centrifugation chamber and exposed to 1.8 g for 55 
about 20 minutes. After an initial time of about 2 minutes to 
Fig. 4 Results of ATOVC measurements from two representative ENaC 
overexpressing oocytes at 1 g and 1.8 g. Hypergravity was achieved using 
a Large Diameter Centrifuge. After a short stabilisation time of about 2 
min, the relative changes of the total current at 100Na and the relative 60 
changes of the amiloride-sensitive current over a time course of 18 
minutes were recorded. The transoocyte potential was held constant at -
100 mV. 
allow cell settlement on the hole, the complete experimental 
protocol, including solution exchange and current recording, 65 
was remotely triggered at defined time intervals varying from 
90 seconds to 5 minutes.  
 In Fig. 4 the relative changes of total and amiloride-
sensitive currents are shown for an oocyte overexpressing 
ENaC that was exposed to hypergravity and compared to the 70 
results obtained for another oocyte exposed to the same 
experimental protocol at 1 g but with an immobilisation 
pressure of 20.5 mbar to account for the increased hydrostatic 
pressure under hypergravity. Analysis of the data revealed 
that under these conditions, the amiloride-sensitive current 75 
increased to 150 % of the initial value, whereas the total 
current decreased slightly (Fig. 4). In contrast, for the oocyte 
on the ground (1 g), we observed an insignificant change in 
amiloride-sensitive current, and a slight decrease in the total 
current (leak plus oocyte current), which was comparable to 80 
the 1.8 g experiment. Taken together, these findings indicated 
that the increase in amiloride-sensitive current under 
hypergravity could not be attributed to either changes in patch 
size (i.e. an increase in the number of channels exposed to 
amiloride) or leak conductance. These findings strongly 85 
suggested that exposure to hypergravity appeared to influence 
the sodium conductance mediated by ENaC.  
Measurements during a parabolic flight  
Two ATOVC systems were fixed on a stable baseplate, which 
was mounted within a metal enclosure in the aeroplane used 90 
for parabolic manoeuvres (Fig. S7). It was mandatory that no 
access to the enclosure was possible during each set of 
parabolic manoeuvres and therefore the entire measurement 
protocol was fully automated, with controls and real-time 
monitoring via a customised touch-screen interface. Each 95 
manoeuvre comprised two hyper-g (ca. 1.8 g) phases that 
bracketed the nominal micro-g phase. A typical flight 
involved a total of 31 such manoeuvres. Before the flights, 
oocytes were freshly prepared and stored on site. They were  
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Fig. 5 (a) Differential current of an ENaC overexpressing oocyte recorded 
during a parabolic flight manoeuvre. The I-V curve for each acceleration 
level was subtracted from that recorded prior to the manoeuvre. The 1 g 
trace was obtained by subtracting the I-V curves taken directly before and 
after the manoeuvre. Linear regression was applied to the datasets 5 
yielding the change in conductance for the slope (Pearson’s coefficients 
are shown on the bottom right of the graph) (b) Plot of the relative 
differential conductance resulting from the I-V data shown in a. (c) 
Readout of the on-board accelerometer during a parabolic manoeuvre. 
The sense of the acceleration vector was from the upper compartment of 10 
the core module to the microperfusion channel. 
introduced into the core module prior to each set of 5 
parabolas.  
 Fig. 5a shows first data obtained from an ENaC 
overexpressing oocyte that was exposed to several hyper- and 15 
microgravity phases. Here we compared for a single oocyte 
the change in total current (leak plus transoocyte current) of 
each phase with respect to the normal gravity condition before 
the manoeuvre. By subtracting the I-V data obtained during 
each phase from the I-V curve before the manoeuvre, the 20 
difference in transoocyte conductance is obtained. The 
resulting I-V curves can be fitted with a linear function from 
which we can estimate the transoocyte conductance. In our 
case, changes in transoocyte conductance were seen during 
hyper- and zero gravity conditions (Fig. 5b, c). Comparison 25 
with the conductance before and after the parabolic 
manoeuvre showed no significant change, which suggested 
that the oocyte reverted to initial conditions after the 
manoeuvre. The origin of these phenomena has yet to be 
elucidated, and it appears unlikely that they result from 30 
systematic errors due to alternating changes in leak resistance 
during micro- and hypergravity, which we found to be 
minimal. In particular, the contribution of the gravitational 
force to the total force acting on the entire oocyte can easily 
be estimated. For a typical oocyte diameter of 1 mm and a 35 
stabilising air pressure of 20 mbar, the gravitational force is 
approximately 1000-fold smaller than the force applied to the 
oocyte via positive pressure.§ The contribution of the change 
in hydrostatic pressure (approx. 0.5 mbar per g) to the leak 
conductance is less than 2 nA at -50 mV transoocyte voltage 40 
(Fig. S6b). Therefore, we believe that the changes can indeed 
be assigned to the response of the oocyte to alteration in the 
gravity level. However, further studies are required to confirm 
the results and reveal the underlying mechanisms. 
Conclusions 45 
We describe a system for performing non-invasive 
electrophysiological measurements on Xenopus laevis oocytes 
under varying gravity levels. Benchmark experiments 
conducted in the laboratory demonstrate that our system is 
able to faithfully reproduce the results typically obtained by 50 
the TEVC method. Furthermore, due to the high stability of 
the leak current, we were able to measure changes in current 
with nanoampere resolution. Initial results on ENaC 
overexpressing oocytes exposed to micro- and hypergravity 
have been presented that suggest ENaC activity is indeed 55 
sensitive to gravitational forces. Future analysis of other ion 
channel classes under micro- or hypergravity will certainly 
provide additional biologically relevant insights, into which 
physiological pathways are affected by gravitational change. 
 The key advantages of this system, in accordance with our 60 
stringent design criteria, are: (i) the very short time needed for 
setup and measurement, (ii) capability of fully automatic 
operation (after mounting the oocyte) and (iii) high reliability. 
Although the system was developed specifically for 
electrophysiological studies under varying gravity conditions, 65 
due to its operational simplicity it could also be conveniently 
used for electrophysiological investigations in ground-based 
laboratories. 
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‡ Permeabilisation of the body membrane could also be achieved using 
ionophores as demonstrated by Dahan et al.14 In the present design, a 
perfusion pathway was already incorporated (Fig. 1b) to allow changes in 
upper compartment composition and this could be adapted for the 85 
permeabilisation procedure 
 
§ For this calculation the values for the force resulting from the air 
pressure and the oocyte weight are assumed to be 4πR2p and 4/3πR3ρg, 
respectively. For ρ we chose a value of 1.2 g/cm3 due to the oocyte’s 90 
slightly higher mass density compared to water. 
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 Supplementary information 
 
Description of the ATOVC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S1 Simplified schematic of the ATOVC (not drawn to scale) as used for the experiments described, in which the body membrane exposed to the upper 
compartment fluid is permeabilized to gain electrical access to the cytosol and thereby allow voltage clamping of the patch exposed to the lower compartment 
(microfluidic channel). Two electrodes make contact with solution in the upper compartment (Ib, Vb) and lower compartment (Ip, Vp) respectively. The equivalent 
circuit of the boxed region, representing the oocyte positioned in the core module, is also depicted. This is an AC equivalent model used in simulations (see below) 
and omits the membrane potential. Rsb and Rsp represent the equivalent resistances of the electrodes and fluid access to the body (upper) and patch (lower) 
membranes, Rl is the leak resistance, Rb and Cb are the lumped resistance and capacitance of the cell body, Rc is the lumped cytosolic resistance and RP and CP are 
the membrane patch resistance and capacitance, respectively. The voltage clamp electronics comprises two components that connect to the lower and upper 
compartments, respectively: (i) a virtual ground amplifier (Avg) defines the potential in the lower compartment (approximating the potential at the external surface 
of the patch) to 0 V and acts as a transimpedance stage that outputs a voltage proportional to the total current (leak (Ileak) and transoocyte (Ito)); (ii) a feedback 
amplifier arrangement, comprising amplifier Av, a comparator and loop gain amplifier (Aloop) senses the electrical potential in the upper compartment and 
compares a scaled version of this (Av Vb) to the external command voltage input (Vc). The feedback amplifier (Aloop) drives current ( Ileak + Ito) to maintain the 
transoocyte potential at the desired value.  
The arrangement shown in Fig S1 permits voltage clamping of the patch membrane by controlling the cytosolic potential and assumes 
adequate electrical access to the cytosol from the upper compartment has been established. The same arrangement could be used for 
transimpedance measurements. Furthermore, by rearranging the connections to the core module so that the potential in the lower 
compartment is externally defined, and the upper compartment is held at 0 V, a loose macropatch configuration would be created. 
 
Patch surface area considerations 
 
Fig. S2 Left: Micrograph showing the oocyte immobilization site from above. The patch  hole diameter is 0.3 mm. Right: Idealised cross-section of the oocyte 
showing geometrical parameters. 
The patch opening diameter was chosen on the basis of maintaining cell stability, considerations of the electrical properties of the cell 
and having rapid superfusion of the exposed area. Too large an opening would result in poor electrical access to the cytosol whereas too 
small an opening would compromise the signal-to-noise ratio for the patch current.  
The surface area (S) of a sphere with radius r is given by: S = 4 π r2.  
The patch area (curved surface area of the cap) is calculated using the following equations: SP= 2 π r h with . 
where, h is the height of the patch and a the patch radius. For a sphere with r=0.5 mm (typical for Xenopus laevis oocytes) and a =0.15 
mm (Fig. S2) the surface area ratio is:  
    . 
 
 
Page 9 of 18 Lab on a Chip
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S3 The dependence of the surface ratio (a) and voltage ratio (b) plotted as function of the patch  hole diameter. The values were obtained by simulation (Fig. 
S4) for a typical oocyte diameter of 1 mm and an AC clamp voltage at 10 Hz. Actual values chosen for our design are indicated (dashed lines/red symbols). 
 
The relationship between the impedance ratio of the two membrane parts and their respective surface areas can be expressed using the 
following equation: 
 
where r: radius of the oocyte and SP: patch area. Here we take the apparent geometrical areas and ignore the increased surface area of the oocyte due to the 
microvilli and invaginations. This would simply scale the calculated areas equally. 
 
Assuming homogeneous distribution of membrane conductance the membrane impedances of the two regions will differ, according to the 
ratio of the membrane areas of each region. Consequently, changes in the transoocyte current will mainly result from changes in the 
impedance of the patch membrane due to its much higher impedance compared to the impedance of the body membrane.  
 Thus, even though the oocyte is effectively voltage clamped across two membranes, the largest fraction of applied AC voltage falls 
across the patched membrane, i.e. by having a large ratio between the non-patched area and the patched area, a voltage clamp from the 
cytosol across a single membrane is approximated (Fig. S3b). In practice, the measured values will deviate somewhat from the calculated 
values due to the deformation of the immobilized oocyte. Nevertheless, this relation is useful for comparing membrane currents of the 
ATOVC with membrane currents measured with a conventional instrument (TEVC). Moreover, to simplify the analysis, this model 
ignores the effect of inhomogeneities of membrane access resistance close to the patch hole.  
 
AC impedance analysis of the ATOVC 
 
Fig. S4 Bode plot of the equivalent circuit of the ATOVC (made using LT SPICE IV (Linear Technologies)). The absolute values for the resistances and 
capacitances are rough estimates. The DC resistance of the entire circuit is typically around 150 kΩ. 
A SPICE AC analysis using estimated values for the ATOVC reveals that the patch impedance is reasonably constant up to frequencies around 1 
kHz (Fig. S4). 
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TEVC reference measurements 
 
Fig. S5 (a) Real-time TEVC recording of membrane current from a representative oocyte expressing ENaC and voltage clamped to -50 mV. (b) I-V data from 
ENaC expressing oocytes (n = 7). Amiloride-sensitive currents were normalized to the current at -100 mV and data pooled (mean ± sem). 
 
Influence of pressure variations on the leak conductance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S6 (a) Time-dependent measurement of leak current varying the air pressure acting on the native oocyte. The transoocyte voltage and the perfusion flow rate 
were kept constant at -50 mV and 2 µl/s (200 mbar), respectively. (b) Statistical evaluation of 5 oocytes subjected to air pressure variation of 1 mbar in both 
directions (base pressure 20 mbar). (c) Time-dependent measurement of the leak current varying the perfusion  pressure in the microchannel. (d) Scheme showing 
the direction of the forces (arrows) involved in the experiment. 
 
To study the influence of air pressure variations on the leak conductance a series of experiments were conducted where either the air 
pressure (Fig. S6a) or the perfusion pressure (Fig. S6c) was varied. These tests demonstrate the system’s susceptibility to variations in 
the immobilization pressure (top pressure) and tolerance to the hydrodynamic resistance of the individual solution pathways. All tests 
were conducted on native oocytes which have negligible membrane conductance compared to the leak. Therefore, the current resulting 
from an applied transoocyte voltage is predominantly leak current. 
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